834 reports of this reaction
3.4% of all SELINEXOR reports
#7 most reported adverse reaction
ASTHENIA is the #7 most commonly reported adverse reaction for SELINEXOR, manufactured by Karyopharm Therapeutics Inc.. There are 834 FDA adverse event reports linking SELINEXOR to ASTHENIA. This represents approximately 3.4% of all 24,395 adverse event reports for this drug.
Patients taking SELINEXOR who experience asthenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ASTHENIA is moderately reported among SELINEXOR users, representing a notable but not dominant share of adverse events.
In addition to asthenia, the following adverse reactions have been reported for SELINEXOR:
The following drugs have also been linked to asthenia in FDA adverse event reports:
ASTHENIA has been reported as an adverse event in 834 FDA reports for SELINEXOR. This does not prove causation, but indicates an association observed in post-market surveillance data.
ASTHENIA accounts for approximately 3.4% of all adverse event reports for SELINEXOR, making it a notable side effect.
If you experience asthenia while taking SELINEXOR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.